← All candidates
2 insider filings on record.
9 filings on record.
ALDXAldeyra Therapeutics, Inc.
NasdaqCM · Healthcare · $83.55M
$1.46
-2.67% · Sep 10
2 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily◆ 7 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$83.55M
Float
48.9M
81% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Principal Financial Officer
Alfieri Michael
Bought $13.3K on Aug 13 — 2,500 sh @ $5.30, held direct, 100% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$7.60 avg target
+420.5% vs today · 5 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
9 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice